Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-03

Clinical Trial Update: Testing a Novel Barrier Cream for Fecal Incontinence in an Ambulatory Population [NA]

View source ↗

Summary

Clinical trial update for a novel barrier cream to prevent moisture-related skin damage and dermatitis in fecal incontinence; recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel barrier cream

Snippet

Sponsor: Scotiaderm | Conditions: Moisture Associated Skin Damage, Fecal Incontinence | NA | Status: NOT_YET_RECRUITING